Posts on ‘November 5th, 2009’

Agreement Allows Immediate Access to EquivaBone(R), a Unique Osteoinductive and Osteoconductive Material With Superior Handling Qualities CARLSBAD, Calif., Nov. 5, 2009 –(HSMN NewsFeed) — Alphatec Holdings, Inc. (Nasdaq:ATEC ), the parent company of A…
Devices, Distribution, Neurosurgery, Orthopaedic
Alphatec Holdings, ETEX Corp, EquivaBone, CarriGen, demineralized bone matrix

BOTHELL, Wash., Nov. 5 (HSMN NewsFeed) — Cardiac Science Corporation (Nasdaq: CSCX ), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced today it appointed veteran healthcare executive Ronald A…
Devices, Cardiology, Monitoring, Personnel
Cardiac Science, automated external defibrillator

SOUTH SAN FRANCISCO, CA and DEERFIELD, IL, Nov. 5 — (HSMN NewsFeed) - Theravance, Inc. (NASDAQ:THRX ) and Astellas Pharma US, Inc. announced today the commercial launch of VIBATIV(TM) (telavancin) in the United States. On September 11, 2009, the U.S. Food…
Biopharmaceuticals
Theravance, Astellas Pharmaceutical US, VIBATIV, telavancin, cSSSI

FRAZER, Pa., Nov. 5 (HSMN NewsFeed) — Cephalon, Inc. (Nasdaq: CEPH ) today announced the journal Cancer has published a pivotal study demonstrating that TREANDA(R) (bendamustine HCl) for Injection induced durable responses in patients with indolent B-ce…
Biopharmaceuticals, Oncology
Cephalon, TREANDA, bendamustine, non-Hodgkin’s lymphoma